Indevus Pharmaceuticals, Inc. Declared termination of the enrolment in Protocol MDP 301, clinical court of the Phase III on ABOUT 2000, Company possible vaginal microbicide for prevention HIV and other sexual sent infection. Test is subsidized by Medical Research Advice United Kingdom (MRC) and is organized by Program of the Development Microbicides (MDP), international partnership of the researchers installed to develop microbicides for prevention of the transmission HIV. This test enrolled 9,395 womans in clinic in South Africa, Tanzania, Uganda, and Zambii. It Is Expected that Results thereof test will be available by the end of 2009.

This - a second big test, testing safety and efficiency 0.5% dose ABOUT 2000 and most big trial of any microbicide to date. (Read ‘Pharmaceuticalses Indevus Declares Termination of the Enrolment’…)

Dr Peter Carter, President to Companies & General Secretary of the Royal College of the Nursing (RCN), said:

“Sisters are often first point of the contact when work with sexual questions of health, and this year subject for Sexual Week of Health, She - My Right! provides the possibility to train on how to provide the specific advice and information on sexual health for people with study of disability.

” It is Important healthcare professionals, and indeed public, understand the problems and sensitivity to sexuality and sexual health, even more so that for people with study of disability who it is necessary additional support.

” RCN Supports Planning to Families to Assotiations of the measures to raise privity about issue of sexual health for people with study of disability and promote healthcare professional, including to lead in promoting this campaigns in society.

“We urge the Government to promote be invested on formation and preparing the possibilities for in the field of and for that solving lay on sexual health. (Read ‘RCN SUPPORTS Sexual Week of Health 4 - 10 August’…)